Kinon, B.J., Lu, Z., Millen, B.A., et al. (2011) A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients with DSM-IV Schizophrenia. Journal of Clinical Psychopharmacology, 31, 349-355.